MSTS/Sarcoma Strong Inc. - STL Cure Sarcoma Research Award - DEADLINE - March 23, 2026
Sarcoma Strong Inc. through a generous collaboration with STL Cure Sarcoma organization, will support the MSTS to provide $50,000 one-year grants for impactful sarcoma research.
Eligibility: The Principal Investigator (PI) or Co-Investigator must be an MSTS member in good standing at an institution with an appropriate research infrastructure. Recipients of prior MSTS grants within the past two years will not be eligible. Recipients of NIH R01/R03/R21 or K-grants, DOD, NSF, and OREF grants are eligible to apply.
The application deadline is March 23, 2026.
Click here to view the Research Funding Announcement.
MSTS/Sarcoma Strong Inc. Mentored Research Award - DEADLINE - March 23, 2026
Sarcoma Strong Inc. will support the MSTS to provide $25,000 one-year grants for developing research under the direction of an experienced mentor in sarcoma research.
Eligibility: Applicants should be at least MSTS Candidate Members within their first 6 years of faculty appointment. Mentors do not need to be MSTS members or from the same institution but should have an independent research program and mentoring experience. Applicants should articulate concrete plans for the development of grant-writing skills and should state how the Mentored Research Award will generate preliminary data for future applications. Recipients of prior or simultaneous major NIH, DOD, NSF, or equivalent funding will not be eligible.
The application deadline is March 23, 2026.
Click here to view the Research Funding Announcement.
Benign Musculoskeletal Tumor Research Award - DEADLINE EXTENDED to October 13, 2025
The MSTS, in partnership with the OREF, will provide a $25,000 one-year grant for innovative research in benign musculoskeletal tumors (BMT).
Eligibility: One member of the study team must be an MSTS member in good standing at an institution with an appropriate research infrastructure. Recipients of NIH R01 or equivalent federal grants, K- grants, and prior OREF grants are eligible to apply.
Bone Metastasis Research Award - DEADLINE EXTENDED to October 13, 2025
The MSTS, in partnership with the OREF, will provide a $25,000 one-year grant for innovative research in metastatic bone disease (MBD).
Eligibility: One member of the study team must be an MSTS member in good standing at an institution with an appropriate research infrastructure. Recipients of NIH R01 or equivalent federal grants, K- grants, and prior OREF grants are eligible to apply.
Additional MSTS/Sarcoma Strong Award Resources
Click here to view the NIH Definitions of Rigor.
Click here to view the NIH Review Criteria.